Pfizer
PFE
🕒 Price Jul 28, 23:30 ET
The overall grade and 100-point score are Premium-only. The 6-metric analysis below is free.
See Premium →Investment caution signals
Automatic signals from DART filings and price trends. “Filing” items are detected from the last 180 days of electronic disclosures. Verify facts against the original filings/news. Not a buy/sell recommendation.
💰 Valuation at a glance
Yahoo FinancePrice ÷ EPS. Lower is cheaper vs earnings. Forward-earnings basis.
Theoretical fair value from PER/PBR and upside (under/overvalued) at a glance. Unlock on Premium.
See Premium →📊 Price trend
Open in Multi-chart →Yahoo Finance📈 Key metrics
Yahoo Finance🏢 Peer comparison
Health CareSide by side with the largest names in the same sector. Green beats the sector median.
| Stock | PER | PBR | ROE | Dividend |
|---|---|---|---|---|
| PfizerCurrent | 18.8× | 1.60× | 9.0% | 7.0% |
| Lilly (Eli) | 42.5× | 34.96× | 77.8% | 0.5% |
| Johnson & Johnson | 30.9× |
🏦 Dividend vs deposit rate
This stock's 6.97% dividend is +2.97%p higher than 1Y Treasury yield (4.00%)
⚠️ Unlike a deposit, a dividend comes with principal (price) risk. Even if the yield beats the rate, a falling price can still mean an overall loss. Treat dividend as just one reference metric.
As of: U.S. Treasury Par Yield (1Y) · 4.00% (2026-05)
📡 Technical signals
📊 Uptrend alignment (short-term bullish) · RSI 56 neutral
Above the moving averages means short-term bullish; below means bearish. RSI ≥ 70 is overbought and ≤ 30 is oversold.
🎮 What if you had bought?
If you'd bought Pfizer in the past, what would it be worth now? Play with the period and amount. (For reference · not a buy recommendation)
※ Simple close-price math, excluding fees, taxes and dividends. Past returns don’t guarantee future results.
📰 Related news
Source: Naver Finance (KR) · Yahoo Finance (US) · external article links
💼 Financial statements
Yahoo FinanceRecent annual
| Period | Revenue | Op. income | Net income | Op. margin |
|---|---|---|---|---|
| 2025 FY | $62.58B | $17.41B | $7.77B | 27.8% |
| 2024 FY | $63.63B | $14.94B | $8.03B | 23.5% |
| 2023 FY | $59.55B | $4.42B | $2.12B | 7.4% |
| 2022 FY | $101.17B | $38.12B | $31.37B | 37.7% |
Quarterly results (last 5 quarters)
📚 Metrics & scoringShow moreCollapse
🔎 Data sources & methodologyShow moreCollapse
Every score is auto-computed from the public data below. No manual adjustment.
| Item | Source | Method · update cadence |
|---|---|---|
| Price · volume · 52W | Yahoo Finance | Stored as-is · hourly intraday |
| Financials (revenue, profit, equity, debt) | Yahoo fundamentalsTimeSeries | Annual + quarterly reported · refreshed over ~1 week |
| Short-term (TTM) score | Computed (quarterly financials) | Sum of last 4 quarters + YoY momentum vs same quarter a year ago · daily |
| PER · PBR | Yahoo reported (US) | Yahoo priceToBook · trailingPE |
| Dividend yield | Yahoo Finance | Annual dividend ÷ price · 0% if none |
| ROE · operating margin · debt ratio |